One-Step ELISA Kits: Why Protein Quantification Is Moving from Multi-Step to Single-Step
ELISA and the Persistent Appeal of the Sandwich Format
Since it was introduced in the 1970s, enzyme-linked immunosorbent assay (ELISA) has remained the accepted gold standard for protein quantification, largely on the strength of its sensitivity and throughput. The technique immobilises a soluble antigen or antibody on a solid support such as polystyrene and exploits specific antigen-antibody recognition for qualitative and quantitative detection. An enzyme-labelled partner binds the immobilised target to form an immune complex; adding substrate generates a coloured product whose absorbance reports the concentration of the target.
Four classical strategies divide the ELISA landscape, each with a distinct operating envelope:
- Direct ELISA: antigen is coated and detected by an enzyme-labelled antibody — simple, but lower sensitivity.
- Indirect ELISA: a primary antibody binds the antigen and an enzyme-labelled secondary antibody supplies signal amplification, improving sensitivity.
- Sandwich ELISA: capture and detection antibodies recognise two distinct epitopes on the same target — the most specific format, and the most widely used today.
- Competitive ELISA: suited to small-molecule antigens, quantifying by competition between sample antigen and labelled antigen for a limited number of antibody binding sites.
Sandwich ELISA dominates cytokine, hormone and disease-biomarker measurement precisely because specificity and sensitivity are the parameters that matter most in those applications. The interesting engineering question is not which format to use, but how far the sandwich workflow itself can be compressed without surrendering either property.
From Three Steps to One: Compressing the Incubation Chain
The double-antibody sandwich assay has followed a clear and deliberate evolutionary path.
- Conventional three-step incubation. Coating antibody → blocking → sample incubation → wash → detection antibody incubation → wash → enzyme-labelled antibody incubation → wash → colour development. Each step is independent, and the full run takes 4–6 hours.
- Two-step incubation. The detection antibody and enzyme-labelled secondary antibody are merged into a single step, or blocking and sample addition are combined. One wash and one incubation are eliminated, compressing the cycle to 2–3 hours.
- One-step incubation. The tag antibody is pre-coated on the plate, while the capture antibody, detection antibody and enzyme-labelled microspheres of the capture-detection system are pre-positioned in the well. After adding sample, a single incubation and a single wash complete the assay, cutting total hands-on time far below conventional formats.
The direction of travel is unmistakable: researchers are consistently trading operator effort for automation-friendly simplicity, working toward a "sample in – result out" assay.
Notes
- Reported run times in this section describe the conventional manual sandwich workflow; actual timings vary with kit format and instrument platform.
- Step consolidation must not come at the cost of the wash efficiency that governs background signal.
What One-Step Consolidation Actually Solve
The advantages of the one-step format differ by user, which is why the same technical change matters for quite different reasons.
For research laboratories
Two-step protocols require multiple reagent components and repeated dilutions. The workflow is long, and every additional pipetting step is an opportunity to introduce error. Pre-positioning the detection antibody in the well reduces the assay to sample addition and a single wash, shortening turnaround and lowering operator-introduced variability.
For industry — biopharma, CRO and CDMO
In preclinical research and quality testing, long detection times, high cost, limited accuracy and poor stability translate directly into failed experiments and higher operating cost. A standardised one-step workflow is better suited to large-scale, industrialised and automated operation.
For clinical and diagnostic laboratories
Slow, inefficient two-step assays limit sample throughput. A faster one-step workflow shortens the interval from sample to result, which supports more timely clinical decision-making.
Crucially, these gains are not purchased with performance. The one-step format maintains sensitivity and specificity comparable to conventional ELISA while substantially reducing the number of operations, which lowers both intra-assay and inter-assay coefficients of variation — a benefit that matters most in applications demanding high reproducibility.
Choosing a One-Step Kit: What to Check First
Because "one-step" describes a workflow architecture rather than a performance guarantee, kit selection still turns on sample matrix, analyte range and the assay's validated claim. The following points are the ones that most often decide whether a one-step kit fits an experiment.
| Selection criterion | Why it matters | What to look for |
|---|---|---|
| Sample matrix | Serum, plasma, culture medium and cell lysate differ markedly in interference profile | A kit explicitly validated for your matrix (for example serum/plasma or culture medium) |
| Species and target | Cross-species kits are convenient but can mask matrix effects | Species coverage stated on the datasheet (human, monkey, mouse, rat) |
| Detection range | An unnecessarily wide range costs sensitivity at the low end | Reported range and sensitivity together, not range alone |
| Precision | Intra- and inter-assay CV govern whether small differences are resolvable | Reported %CV for both, ideally in your target matrix |
| Workflow tolerance | Fewer steps still requires disciplined pipetting and timing | Clear instructions on incubation time and temperature |
One-Step ELISA Kits for Cytokine, Chemokine and Antibody Readouts
ANTBIO's OneStep ELISA range applies the consolidated single-incubation architecture across a set of targets that routinely appear together in immunology, drug development and biomarker screening workflows. Each kit below uses a pre-coated tag antibody together with a pre-positioned capture-detection system that carries the capture antibody and the detection antibody/HRP microspheres.
Part 1 · Chemokine kits matched to sample matrix
Matrix determines format more often than target does. The CXCL10/IP-10 pair below shares a target but is split by sample type — the most direct illustration of the selection logic described above.
| Cat. No. | Product | Target class | Sample matrix |
|---|---|---|---|
| S0C3103 | Human & Monkey CXCL10/IP-10 (serum/plasma) OneStep ELISA Kit | Chemokine | Human and monkey serum / plasma |
| S0C3102 | Human CXCL10/IP-10 (Culture Medium) OneStep ELISA Kit | Chemokine | Cell culture medium |
| S0C3093 | Mouse & Rat CCL17 (Culture Media) OneStep ELISA Kit | Chemokine | Cell culture medium |
| S0C3094 | Mouse & Rat CCL17 (Serum & Plasma) OneStep ELISA Kit | Chemokine | Mouse and rat serum / plasma |
A worked example of the split logic: the Human & Monkey CXCL10/IP-10 (serum/plasma) OneStep ELISA Kit (S0C3103) combines a one-step immunoassay architecture with a pre-coated tag antibody and a pre-positioned capture-detection system carrying detection antibody/HRP microspheres, and is intended for rapid quantification of CXCL10/IP-10 in human and monkey serum or plasma — supporting immunology research, drug development and biomarker screening. When the same analyte is measured in cell culture supernatant rather than blood, the culture-medium kit (S0C3102) is the validated match.
Part 2 · Cytokine and immunoglobulin kits sharing the same architecture
These targets typically run alongside chemokine panels in the same sample batch, so a shared one-step format removes day-to-day workflow variation between them.
| Cat. No. | Product | Target class | Typical application |
|---|---|---|---|
| S0C3068 | Human IFN-β (Culture Medium) OneStep ELISA Kit | Type I interferon | Interferon pathway studies in cell culture |
| S0C3001-HL | Human IL-2 OneStep ELISA Kit (High Level) | Th1 cytokine | T-cell activation and proliferation assays |
| S0C3024-HL2 | Human TNF-α OneStep ELISA Kit | Pro-inflammatory cytokine | Inflammation and polyfunctional T-cell readouts |
| S0C3196 | Human E-Selectin/CD62E OneStep ELISA Kit | Adhesion molecule | Endothelial activation and inflammation research |
| S0C3198 | Human IgG3 OneStep ELISA Kit | Immunoglobulin subclass | Humoral response characterisation |
Notes
- Kit-specific detection ranges, sensitivities and precision values are stated on each product datasheet; the tables above list catalog numbers, target classes and validated sample matrices only.
- All catalog numbers above resolve to live product pages on antbioinc.com at the time of writing.
Shorten the Workflow Without Shortening the Data
If your bottleneck is hands-on time rather than assay sensitivity, a one-step format can remove steps without removing rigour. Tell us your sample matrix and target, and we will match it to the appropriate OneStep kit and share the relevant performance data. For product details, datasheets or a quotation, contact us at info@antbioinc.com.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
ANT BIO PTE. LTD. supplies high-quality reagents and solutions for life science research. Our sub-brands cover the full research workflow: Starter for antibodies and immunological assay kits, UA-Bio for recombinant proteins and drug discovery solutions, and Absin for general reagents and other detection kits. Explore our product portfolio at www.antbioinc.com.
